Post-Mortem Review and Genetic Analysis of Sudden Unexpected Death in Epilepsy (SUDEP) Cases
|
|
- Kelly Woods
- 8 years ago
- Views:
Transcription
1 Brain Pathology ISSN RESEARCH ARTICLE bpa_ Post-Mortem Review and Genetic Analysis of Sudden Unexpected Death in Epilepsy (SUDEP) Cases Emily Tu, BSC 1,2 ; Richard D. Bagnall, PHD 1 ; Johan Duflou, MBCHB 2,3 ; Christopher Semsarian, MB BS PHD 1,2,4 1 Agnes Ginges Centre for Molecular Cardiology, Centenary Institute. 2 Sydney Medical School, University of Sydney. 3 Department of Forensic Medicine, Glebe. 4 Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia. Keywords arrhythmias, genetics, ion channel, SUDEP. Corresponding author: Professor Chris Semsarian, MB BS PHD, Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Locked Bag 6, Newtown, NSW 2042, Australia ( c.semsarian@centenary.org.au) Received 12 July 2010; accepted 13 August doi: /j x Abstract Sudden unexpected death in epilepsy (SUDEP) is the most frequent epilepsy-related cause of death and is characterized by an absence of any identifiable cause of death at postmortem, suggesting an underlying arrhythmogenic predisposition. This study sought to identify SUDEP cases in a review of post-mortem records and to undertake genetic studies in key familial long QT syndrome (LQTS) genes. All autopsies performed from at a forensic centre in Sydney, Australia were reviewed and SUDEP cases identified. DNA was extracted from post-mortem blood and the three most common LQTS genes, ie, KCNQ1, KCNH2 (HERG) and SCN5A, were amplified and analyzed. Sixty-eight SUDEP cases were identified (mean age of years). Genetic analysis revealed 6 (13%) non-synonymous (amino acid changing) variants in KCNH2 (n = 2) and SCN5A (n = 4), all previously reported in LQTS patients. Specifically, KCNH2 Arg176Trp and SCN5A Pro1090Leu were identified once in SUDEP cases and absent in control alleles. Both DNA variants have been previously identified in the pathogenesis of LQTS. The cause of SUDEP is currently unknown. Our results indicate that investigation of key ion channel genes should be pursued in the investigation of the relationship between epilepsy and sudden death. INTRODUCTION Epilepsy is one of the most prevalent neurological conditions. People with epilepsy have a higher risk of mortality compared with healthy individuals (1, 2). While a proportion of these deaths have been attributed to suicide, accident or convulsive status epilepticus (3), a subgroup of patients with epilepsy die suddenly, in otherwise apparently good health, from an unknown cause of death. This phenomenon describes sudden unexpected death in epilepsy (SUDEP) and, with a reported occurrence of up to 18% of all deaths in people with epilepsy (4, 5), is the most frequent epilepsy-related cause of death (6). A number of risk factors for SUDEP have been proposed including young age, presence of generalized tonic-clonic seizures, poor anti-epileptic drug (AED) compliance, use of multiple AEDs, duration of the seizure disorder ranging from years and early onset of epilepsy (7). The exact mechanisms underlying SUDEP remain unknown. Seizure-related abnormalities of respiratory and cardiac function have both been implicated as possible contributors (8), and the most commonly suggested terminal event is a cardiac arrhythmia during and between seizures. Notably, SUDEP is characterized by an absence of any identifiable structural cause of death at post-mortem, suggesting that an underlying arrhythmogenic predisposition may exist (9, 10). The most common proposed pathogenic mechanism underlying sudden unexplained death is heritable arrhythmogenic syndromes, or cardiac channelopathies, such as familial long QT syndrome (LQTS). LQTS associated with syncope, seizures and sudden cardiac death (SCD) is caused by mutations in more than 10 genes, of which 8 encode ion channels and their subunits (11 20). Over 80% of these LQTS mutations are identified in three genes encoding cardiac potassium or sodium ion channels; namely KCNQ1, KCNH2 (HERG) and SCN5A (21, 22). Alterations in these ion channel genes may result in a prolonged QT interval, ultimately leading to an increased susceptibility to ventricular arrhythmias and SCD. A genetic predisposition to the development of a cardiac arrhythmia may also represent a possible pathogenic mechanism in the sudden death of patients with epilepsy. This study sought to characterize a large cohort of SUDEP cases from a review of post-mortem reports and to identify variants in the three most common LQTS genes that may contribute to the development of cardiac arrhythmias and sudden death in SUDEP. METHODS Study cohort Post-mortem reports over a 16-year period from 1993 to 2009 at the Department of Forensic Medicine, New South Wales (NSW), Brain Pathology (2010) 1
2 Genetic Basis of SUDEP Tu et al Australia, were reviewed in detail. The ISYS Query database system (ISYS Search Software, Sydney, NSW) was used to identify SUDEP cases by performing a search for all autopsy reports containing the words epilepsy, sudden and death. Records matching this word search were extracted and, in each case, all available demographic, clinical and autopsy data were collected. Police and ambulance reports were also examined. SUDEP cohort inclusion criteria included: a known history of epilepsy (evidence of AED therapy, reported in medical history), died suddenly and unexpectedly, and the post-mortem examination revealed no structural, non-cardiac or toxicological cause of death. Cases with SUDEP reported as the primary cause of death were considered definite SUDEP, while cases with a primary cause of death reported as either epilepsy, complications of epilepsy, consistent with epilepsy, sudden death in association with seizure disorder or undetermined were considered possible SUDEP. This study was approved by the Office of the NSW State Coroner and performed in accordance with institutional human ethics guidelines. Genetic analysis Genomic DNA was prepared from post-mortem blood using the QIAamp DNA Midi Kit (Qiagen, Germantown, MD, USA). The coding regions and intron/exon boundaries of the three most common LQTS genes, i.e. the cardiac voltage-gated potassium channels KCNQ1 and KCNH2, and the cardiac voltage-gated sodium channel SCN5A were analyzed for DNA sequence variants. Primers flanking the intron/exon boundaries were designed to amplify protein-encoding exons of KCNQ1, KCNH2 and SCN5A, in conjunction with previously published SCN5A primers (20, 23). Polymerase chain reaction (PCR) products were analyzed for sequence variants using high-resolution melt (HRM) analysis (24) or DNA sequencing (25), as previously described. In brief, primers for HRM were designed using the LightScanner Design Software v1.0.r.84 (Idaho Technology, Inc., Salt Lake City, UT, USA). Genomic DNA was amplified using HRM Mastermix (TrendBio, Melbourne, Victoria, Australia) and PCR amplicons analyzed using the 96-well LightScanner (Idaho Technology, Inc.) and LightScanner Software v2.0. Samples with abnormal HRM profiles were re-amplified and sequenced to identify DNA variants. PCR products for sequencing were visualized on a 2% agarose gel, DNA sequenced, then analyzed using Sequencher v4.8 (Gene Codes Corp, Ann Arbor, MI, USA). Genotyping of non-synonymous sequence variants using direct DNA sequencing or restriction digestion was performed in at least 340 control alleles. The following criteria were investigated for each non-synonymous variant to determine possible pathogenicity: absence of the variant in at least 340 healthy control alleles; conservation level of the amino acid residue among orthologous proteins; prediction of pathogenicity using the on-line resource PolyPhen, which predicts the possible impact of an amino acid substitution on the structure and function of a human protein on the basis of threedimensional structure and multiple alignment of homologous sequences ( RESULTS A comprehensive review of post-mortem reports from 1993 to 2009 identified a total of 68 SUDEP cases. Twenty-two cases were reported as definite SUDEP and the remaining 46 were considered possible SUDEP. All these cases displayed features typical of SUDEP, including previous report of a healthy state prior to death, died suddenly and unexpectedly, normal toxicology and anatomical histopathology, and no cause of death identified at post-mortem. The mean age of the SUDEP cohort was years (range 5 82 years) with a male predominance of 2:1. Forty cases (62%) were taking AED therapy and 64 cases (94%) were unwitnessed events, were in good health within 24 h of discovery and found deceased in bed. The specific cause of epilepsy was stated in four cases and attributed to motor vehicle accidents or head injuries. The characteristics of these 68 cases are summarized in Table 1. Post-mortem blood was available for 48 of the 68 cases. Genetic analysis of the most common LQTS-causing genes revealed; 11 synonymous variants in KCNQ1 (n = 2), KCNH2 (n = 3) and SCN5A (n = 6); and 6 non-synonymous variants in KCNH2 (n = 2) and SCN5A (n = 4) (Table 2). The non-synonymous variants included Arg176Trp and Arg1047Leu in KCNH2, found in one and four SUDEP cases, respectively, and Ala572Asp, Pro1090Leu and Pro2006Ala in SCN5A, each detected once in three separate SUDEP cases (Table 3). Interestingly, one case was heterozygous for both the KCNH2 Arg1047Leu and SCN5A Ala572Asp rare variants. All non-synonymous variants were genotyped in a control population. The KCNH2 Arg1047Leu variant was identified in 10 of 340 control alleles (2.9%), and was predicted to be possibly damaging by PolyPhen. The SCN5A Ala572Asp and Pro2006Ala variants were, respectively, found in 2 of 340 (0.6%) and 1 of 338 (0.3%) control alleles, and predicted to be benign and possibly damaging by PolyPhen. Of most significance, two variants, KCNH2 Arg176Trp (Figure 1) and SCN5A Pro1090Leu (Figure 2) were absent in at least 340 control alleles, respectively, and both were predicted to be possibly damaging by PolyPhen (Table 2). DISCUSSION This study describes a large cohort of SUDEP cases with genetic screening of the three most common genes known to cause familial LQTS, i.e. KCNQ1, KCNH2 and SCN5A. We identified 68 cases of SUDEP and, to our knowledge, this represents the largest SUDEP cohort reported to date. The high incidence of unwitnessed events with cases found deceased in bed (94%), as well as the frequent use of AED therapy (62%), supports previous reports that these are risk factors for SUDEP. Genetic analysis identified six nonsynonymous variants (13%), of which at least two, KCNH2 Arg176Trp and SCN5A Pro1090Leu, are likely to be involved directly in pathogenesis. These findings suggest a possible pathogenic link between SUDEP, mutations in ion channel genes and familial LQTS. The exact mechanisms underlying the pathogenesis of SUDEP are currently unclear. A genetic susceptibility to the development of a cardiac arrhythmia, independent of (or related to) the epilepsy phenotype, could exist and increase the risk of SCD. One previous single case report has explored the possible role of LQTS gene mutations specifically in SUDEP. Mutation analysis of the LQTSassociated genes KCNQ1, KCNH2, SCN5A, mink and MiRP1 revealed a novel SCN5A Arg523Cys variant in one of four SUDEP cases investigated (26). After genetic screening of our current 2 Brain Pathology (2010)
3 Tu et al Genetic Basis of SUDEP Table 1. Clinical characteristics of 68 SUDEP cases identified. Case Age Gender Definite/possible SUDEP Anti-epileptic drug Other 1 5 F Possible Frequent seizure episodes with recent seizure requiring hospitalization 2 6 F Possible Epilepsy diagnosed at age 5 months; seizures difficult to control with medication; three seizures prior to death 3 7 M Possible Diazepam Cerebral palsy 4 12 M Possible Benign rolandic epilepsy; no prescribed anti-epileptic therapy; seizures during sleep 5 17 F Possible 6 19 M Definite Lamotrigine Epilepsy diagnosed at age 11 years; unwitnessed seizures every 2 3 months and often at night; last seizure 2 weeks prior to death 7 21 M Possible Lamotrigine 8 23 M Possible Lamotrigine History of poorly controlled epilepsy; complained of dizziness prior to death; heavy smoker 9 25 F Possible Intellectual disability; schizophrenia Topiramate F Possible Frequent seizure episodes; family history of seizures F Possible F Definite Last seizure 4 months prior to death M Possible Epilepsy diagnosed 3 4 years prior to death; no prescribed anti-epileptic therapy; epilepsy controlled by diet M Definite Carbamazepine Frequent seizure episodes; intellectual disability F Possible Bipolar disease; alcoholic; insomnia; unwell prior to death F Possible Carbamazepine F Possible Carbamazepine Grand mal epilepsy diagnosed at age 24 years; last seizure 2 days prior to death M Possible Carbamazepine Lamotrigine Obesity; hypertension; seizure prior to death F Possible Carbamazepine Unwell the evening prior to death M Definite Carbamazepine Vigabratin Mild asthma M Possible Lamotrigine Epilepsy diagnosed at age 17 years M Definite Carbamazepine Attention deficit disorder M Definite Carbamazepine Epilepsy diagnosed at age 6 years; frequent seizure episodes M Possible Slight mental disability M Possible Carbamazepine Post-traumatic seizure disorder following motor vehicle accident M Definite Long history of epilepsy; asthma; marijuana user; non-compliant with anti-epileptic therapy and preferred herbal treatment F Possible Dysmorphia; mental disability; partially blind; type 2 diabetes F Definite Lamotrigine Epilepsy diagnosed at age 23 years; non-compliant with antiepileptic therapy 6 months prior to death; fibromyalgia F Possible M Possible Diabetes M Definite Epilepsy diagnosed at age 34 years; 10 reported seizure episodes F Definite Oxcarbazepine Epilepsy diagnosed at age 12 years; partially deaf; frequent seizure episodes at night M Possible Lamotrigine Hypertension; hyperlipidemia F Possible Intellectual disability; cerebral palsy; blind M Definite Lamotrigine M Possible Post-traumatic seizure disorder following motor vehicle accident 7 years ago M Definite Epilepsy diagnosed since birth; non-compliant with anti-epileptic Vigabratin therapy; consumed alcohol against medical advice M Definite Severe epilepsy; severe seizures once a month; schizophrenia; heavy smoker Brain Pathology (2010) 3
4 Genetic Basis of SUDEP Tu et al Table 1. Continued Case Age Gender Definite/possible SUDEP Anti-epileptic drug Other M Definite Seizures each week; alcohol abuse; heavy smoker M Possible Carbamazepine Hepatitis C positive; intravenous drug user M Possible Carbamazepine Headaches and vomiting prior to death M Possible Seizure prior to death M Possible Lamotrigine Frequent seizure episodes Oxcarbazepine M Possible Carbamazepine Epilepsy diagnosed at age 14 years; seizure prior to death M Definite Frequent seizure episodes; heavy alcohol abuse M Possible Seizure and chest pain prior to death M Possible Carbamazepine Grand mal epilepsy; non-compliant with anti-epileptic therapy over Christmas caused by alcohol consumption M Possible Last seizure at age 14 years; intellectual impairment caused by brain damage at birth; sleep apnea; depression M Definite Heavy smoker M Possible Last seizure 5 weeks prior to death; depression with suicidal ideation M Definite Phenobarbitone Grand mal epilepsy; viral encephalitis at age 14 years; obesity M Definite Post-traumatic seizure disorder following motor vehicle accident at age 18 years; smoker M Possible Behavioral problems; moderate developmental disability Lamotrigine F Possible No seizure episode 12 months prior to death Topiramate M Possible Epilepsy diagnosed at age 16 years; non-compliant with anti-epileptic therapy; frequent seizure episodes; last seizure 18 months prior to death M Definite Epilepsy diagnosed at age 15 years M Possible Carbamazepine M Possible Post-traumatic seizure disorder following head injury; alcohol abuse; hepatitis C infection M Definite Diagnosed with intracerebral hemorrhage after which developed seizure disorder; liver cancer M Possible Epilepsy diagnosed at age 58 years; frequent seizure episodes; type 2 diabetes; hypertension; hypercholesterolemia F Definite Grand mal epilepsy; hypertension; severe encephalitis M Possible Carbamazepine Controlled hypoglycemia by diet F Possible Heavy alcohol consumption F Possible Carbamazepine Epilepsy diagnosed at age 16 years M Definite Carbamazepine M Possible F Possible Hypertension F Possible Hypertension Non-synonymous variants were found in these SUDEP cases. The cause of epilepsy was known caused by a previous motor vehicle accident or head injury. larger SUDEP cohort, 17 variants were found in the KCNQ1, KCNH2 and SCN5A genes, of which 6 (13%) were rare nonsynonymous variants in KCNH2 (Arg176Trp and Arg1047Leu) and SCN5A (Ala572Asp, Pro1090Leu and Pro2006Ala). All of these six non-synonymous variants identified in the current study have been reported previously in cases of LQTS (22, 27 32). The KCNH2 variant at codon 176 (Arg176Trp) is a nonconservative substitution of a polar and positively charged arginine 4 Brain Pathology (2010)
5 Tu et al Genetic Basis of SUDEP Table 2. DNA variants in LQTS genes identified in SUDEP cases. Gene SNP Exon Amino acid change MAF (%) SUDEP (n = 48) Controls (n = 170) dbsnp European controls KCNQ1 rs Ser546Ser rs Tyr662Tyr KCNH2 rs Arg176Trp rs Ile489Ile rs Leu564Leu rs Tyr652Tyr rs Arg1047Leu SCN5A rs Ala29Ala rs His118His 1.0 NA rs His558Arg rs Leu561Leu 1.0 NA rs Ala572Asp rs Glu1061Glu rs Pro1090Leu NA rs Gly1406Gly rs Asp1819Asp rs Pro2006Ala NA Multiple European control groups have been reported and are available in dbsnp. MAF shows the frequency range, ie. the lowest and highest frequency for each variant. MAF, minor allele frequency. The percentage provided is the allelic frequency for the minor allele; NA, MAF is not available in a European control population. Bold indicates likely pathogenic mutations. residue for a non-polar and neutral tryptophan residue in a highly conserved region of the KCNH2 protein N-terminus, and predicted to be probably damaging by the Polyphen prediction program (Figure 1b and 1c). The KCNH2176Trp allele was absent in 360 control alleles, and an online database of single nucleotide polymorphisms (SNPS) lists this allele as absent in the DNA of an additional 555 healthy individuals of European descent, but present once in a further cohort of 46 healthy Europeans. Interestingly, the KCNH2 Arg176Trp variant is reported as one of four common founder mutations associated with a prolonged QT interval in Finnish families with LQTS (29, 31), and was also reported in a case of sudden unexplained death (33). Moreover, functional studies have shown that the Arg176Trp substitution alters channel function in vitro, causing an acceleration in channel deactivation and reducing potassium current density, resulting in a prolonged QT interval (29). Collectively, these results implicate the KCNH2 Table 3. Clinical characteristics of SUDEP cases with protein-changing variants. Case Gene variant Age Gender Cause of death at autopsy Anti-epileptic drug Other 1 KCNH2 Arg176Trp 39 M SUDEP Epilepsy diagnosed at age 34 years 10 reported seizure episodes 2 KCNH2 Arg1047Leu 51 M Complications of epilepsy Lamotrigine Behavioral problems Moderate developmental disability 3 KCNH2 Arg1047Leu 52 M Undetermined Epilepsy diagnosed at age 16 years Non-compliant with anti-epileptic therapy Frequent seizure episodes Last seizure 18 months prior to death 4 KCNH2 Arg1047Leu 59 M Undetermined Epilepsy diagnosed at age 58 years Frequent seizure episodes Type 2 diabetes Hypertension Hypercholesterolemia 5 KCNH2 Arg1047Leu 52 F Undetermined No seizure episode 12 months prior to death SCN5A Ala572Asp Topiramate 6 SCN5A Pro1090Leu 23 M Undetermined Lamotrigine History of poorly controlled epilepsy Complained of dizziness prior to death Heavy smoker 7 SCN5A Pro2006Ala 43 M Undetermined Seizure prior to death Brain Pathology (2010) 5
6 Genetic Basis of SUDEP Tu et al A B Arg176Trp PALLALTAWESSVR Human PALLALTARESSVR Monkey PALLALTARESSVR Dog PALLALTTRESSAR Mouse PALLALTARESSVR Rat Normal PALLALTARESPMR Arg176Trp C PAS domain PAC domain TSR cnbd N 1 C 1159 Arg176Trp IIe489IIe Leu564Leu Tyr652Tyr Arg1047Leu Figure 1. KCNH2 Arg176Trp mutation in SUDEP. A. Sequence chromatograms and B. amino acid conservation of Arg176Trp across species. C. Schematic representation of the linear topology of the KCNH2 protein shows both the location of critical domains and variants identified in cases of SUDEP. PAS = Per-Arnt-Sim domain; PAC = PAS-associated C-terminal domain; TSR = transmembrane spanning region; cnbd = cyclic nucleotide-binding domain. Arg176Trp variant in prolongation of the QT interval, which may lead to a fatal arrhythmia. The SCN5A variant at codon 1090 (Pro1090Leu) is a conservative substitution of a proline to a leucine at a non-conserved residue located between the TSRII and TSRII protein domains (Figure 2). The SCN5A 1090Leu allele was absent in 340 control alleles. This SCN5A 1090Leu variant has been previously reported in Japanese LQTS patients and was considered to be an Asian-specific polymorphism (30, 34). Furthermore, functional studies showed that the 1090Leu allele caused a shift in channel function, which is dependent upon the SCN5A splice variant (35). The presence of this protein-changing variant in the specific SUDEP case in the current study could be associated with an increased susceptibility to sudden death. One SUDEP case was found to carry two rare non-synonymous variants in KCNH2 Arg1047Leu and SCN5A Ala572Asp. Both variants have been reported in cases of LQTS and SIDS, and more importantly Ala572Asp has been identified in women with SCD (22, 27, 28, 31, 32, 36). This is consistent with the findings of our current SUDEP case (Table 1; Case #54), who was a 52 year old female with an undetermined cause of death. Although there has been no report of each variant acting in combination with a second genetic variant, one could speculate that the combined effect of these two protein-changing variants may increase the risk of sudden death in this epilepsy patient. This gene dose effect caused by multiple mutations in the same patient leading to more severe clinical disease has now been reported in a number of other cardiac genetic diseases. The identification of DNA variants in LQTS-causing genes in this large SUDEP cohort supports the hypothesis that alterations in the QT interval may trigger life-threatening ventricular arrhythmias specifically in epilepsy patients. An important recent study reported LQTS patients with a seizure phenotype, i.e. the presence of either a personal or family history of seizures or history of AED therapy were more common in LQTS type 2 compared with all the other subtypes of LQTS (38). In addition, significant prolongation of the QT interval has been reported during seizures in patients with epilepsy (39). The nonsynonymous variants in KCNH2 and SCN5A have been functionally shown to exhibit currents typical of mutations associated with LQTS (27, 29, 35 37). Collectively, these findings support a common hypothesis that ion channels regulating the QT interval are likely to play an important role in the predisposition of epilepsy patients to sudden death. It remains to be determined whether these ion channel variants are the genetic cause or an accompanying risk factor in the sudden death of patients with epilepsy. The variants may act in isolation or require the presence of a second genetic factor or environmental influence, such as uncontrolled seizures, QT-prolonging AEDs, and non-compliance with AED therapy, to predispose epilepsy patients to malignant arrhythmias and sudden death. Unfortunately, a limitation of our study was the inability to contact the surviving relatives of these SUDEP cases. All cases were studied in a de-identified manner as per ethical guidelines and, therefore, there was no available ECG data in the deceased or in family members, and a family history of sudden death, epilepsy and/or LQTS could not be obtained. We were therefore unable to conduct genetic studies in other family members to assess co-inheritance of disease. However, the positive findings of the 6 Brain Pathology (2010)
7 Tu et al Genetic Basis of SUDEP A Normal B Pro1090Leu VSGGPEAPLDSRTW Human VSGGPEAPPDSRTW Chimpanzee VSGGPEAPPDSRTW Dog VSGSPEAVPERGAW Mouse VSGGHEPPQEPRAW Rat VSGGHEPYQEPRAW Chicken VEGWWPLPPASRVV Pro1090Leu C Interacts with NEDD4, NEDD4L and WWP TSR I TSR II TSR III TSR IV IQ domain N 1 C 2016 His118His His558Arg Glu1061Glu Gly1406Gly Asp1819Asp Pro2006Ala Ala29Ala Leu561Leu Pro1090Leu Ala572Asp Figure 2. SCN5A Pro1090Leu mutation in SUDEP. A. Sequence chromatograms and B. amino acid conservation of Pro1090Leu across species. C. Linear topology of the SCN5A protein with the location of each variant found in SUDEP. TSR = transmembrane spanning region; IQ = calmodulin binding region; NEDD4 = E3 ubiquitin-protein ligase NEDD4; NEDD4L = E3 ubiquitin-protein ligase NEDD4-like; WWP2 = NEDD4-like E3 ubiquitin-protein ligase WWP2. current study have provided the proof-of-principle to conduct a more comprehensive prospective study of SUDEP cases. SUDEP is a devastating complication in patients with epilepsy. There is no single risk factor common to all cases and the pathogenic mechanism underlying sudden death in those with epilepsy remains unclear. We report a large cohort of Australian cases of sudden unexpected death in epilepsy and potential pathogenic factors involved in the genetic predisposition to sudden death. Identification of genetic factors that predispose epilepsy patients to the development of cardiac arrhythmias and sudden death will be important in risk factor stratification and provide opportunities for therapeutic intervention to prevent sudden death in individuals with epilepsy. DISCLOSURES There are no conflicts of interest declared by the authors. REFERENCES 1. Hauser WA, Hesdorffer DC (1990) Epilepsy: Frequency, Causes and Consequences,Demos:NewYork. 2. Nashef L, Fish DR, Garner S, Sander JW, Shorvon SD (1995) Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia 36: Gaitatzis A, Sander JW (2004) The mortality of epilepsy revisited. Epileptic Disord 6: Ficker DM (2000) Sudden unexplained death and injury in epilepsy. Epilepsia 41(Suppl. 2):S Walczak TS, Leppik IE, D Amelio M, Rarick J, So E, Ahman P et al (2001) Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56: Nashef L (1997) Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 38:S6 S8. 7. Tomson T, Walczak T, Sillanpaa M, Sander JW (2005) Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia 46(Suppl. 11): Stollberger C, Finsterer J (2004) Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 59: Nashef L, Ryvlin P (2009) Sudden unexpected death in epilepsy (SUDEP): update and reflections. Neurol Clin 27: Surges R, Adjei P, Kallis C, Erhuero J, Scott CA, Bell GS et al (2010) Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: a case-control study. Epilepsia 51: Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW et al (1999) MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97: Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80: Brain Pathology (2010) 7
8 Genetic Basis of SUDEP Tu et al 13. Medeiros-Domingo A, Kaku T, Tester DJ, Iturralde-Torres P, Itty A, Ye B et al (2007) SCN4B-encoded sodium channel beta4 subunit in congenital long-qt syndrome. Circulation 116: Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, dubell WH et al (2003) Ankyrin-B mutation causes type 4 long-qt cardiac arrhythmia and sudden cardiac death. Nature 421: Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A et al (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen s syndrome. Cell 105: Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R et al (2004) Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119: Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT (1997) Mutations in the hmink gene cause long QT syndrome and suppress IKs function. Nat Genet 17: Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW et al (2006) Mutant caveolin-3 induces persistent late sodium current and is associated with long-qt syndrome. Circulation 114: Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ et al (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12: Wang Q, Li Z, Shen J, Keating MT (1996) Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 34: Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL et al (2000) Spectrum of mutations in long-qt syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102: Tester DJ, Will ML, Haglund CM, Ackerman MJ (2005) Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2: Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT (1998) Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics 51: Chiu C, Bagnall RD, Ingles J, Yeates L, Kennerson M, Donald JA et al (2010) Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis. J Am Coll Cardiol 55: Tu E, Bagnall RD, Duflou J, Lynch M, Twigg SM, Semsarian C (2010) Post-mortem pathologic and genetic studies in dead in bed syndrome cases in type 1 diabetes mellitus. Hum Pathol 41: Aurlien D, Leren TP, Tauboll E, Gjerstad L (2009) New SCN5A mutation in a SUDEP victim with idiopathic epilepsy. Seizure 18: Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C et al (2007) Prevalence of long-qt syndrome gene variants in sudden infant death syndrome. Circulation 115: Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ (2004) Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 110: Fodstad H, Swan H, Laitinen P, Piippo K, Paavonen K, Viitasalo M et al (2004) Four potassium channel mutations account for 73% of the genetic spectrum underlying long-qt syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med 36(Suppl. 1): Iwasa H, Itoh T, Nagai R, Nakamura Y, Tanaka T (2000) Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population. J Hum Genet 45: Larsen LA, Andersen PS, Kanters J, Svendsen IH, Jacobsen JR, Vuust J et al (2001) Screening for mutations and polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac HERG/MiRP1 ion channel: implications for acquired and congenital long Q-T syndrome. Clin Chem 47: Paulussen A, Matthijs G, Gewillig M, Verhasselt P, Cohen N, Aerssens J (2003) Mutation analysis in congenital Long QT Syndrome a case with missense mutations in KCNQ1 and SCN5A. Genet Test 7: Tester DJ, Ackerman MJ (2007) Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 49: Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW et al (2004) Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 1: Tan BH, Valdivia CR, Rok BA, Ye B, Ruwaldt KM, Tester DJ et al (2005) Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2: Albert CM, Nam EG, Rimm EB, Jin HW, Hajjar RJ, Hunter DJ et al (2008) Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation 117: Wang DW, Desai RR, Crotti L, Arnestad M, Insolia R, Pedrazzini M et al (2007) Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 115: Johnson JN, Hofman N, Haglund CM, Cascino GD, Wilde AA, Ackerman MJ (2009) Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology 72: Brotherstone R, Blackhall B, McLellan A (2010) Lengthening of corrected QT during epileptic seizures. Epilepsia 51: Brain Pathology (2010)
Diagnostic Scoring System for LQTS
Medical Coverage Policy Genetic Testing: Congenital Long QT Syndrome Device/Equipment Drug Medical Surgery Test Other Effective Date: 2/15/2011 Policy Last Updated: 2/21/2012 Prospective review is recommended/required.
More informationGenetic Long QT Syndrome GENETIC TESTING FOR LONG QT SYNDROME HS-148. Policy Number: HS-148. Original Effective Date: 1/21/2010
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
More informationLong QT. Long QT Syndrome. A Guide for
Long QT Long QT Syndrome A Guide for Introduction Long QT syndrome (LQTS) is a genetic heart disorder due to the malfunction of cardiac ion channels that results in 4,000 deaths annually in the United
More informationAcquired, Drug-Induced Long QT Syndrome
Acquired, Drug-Induced Long QT Syndrome A Guide for Patients and Health Care Providers Sudden Arrhythmia Death Syndromes (SADS) Foundation 508 E. South Temple, Suite 202 Salt Lake City, Utah 84102 800-STOP
More informationEpilepsy 101: Getting Started
American Epilepsy Society 1 Epilepsy 101 for nurses has been developed by the American Epilepsy Society to prepare professional nurses to understand the general issues, concerns and needs of people with
More informationInvestigation of Ion Channel Gene Variants in Patients with Long QT Syndrome
Investigation of Ion Channel Gene Variants in Patients with Long QT Syndrome Ernesto Curty 1, Fernando Eugênio dos Santos Cruz 2, Fabiane Santos Lima 1, Jorge Luiz Albuquerque Coutinho 2, Rosane Silva
More informationThe long-qt syndrome (LQTS) is an inherited or acquired
Compound Mutations A Common Cause of Severe Long-QT Syndrome Peter Westenskow, BS; Igor Splawski, PhD; Katherine W. Timothy, BS; Mark T. Keating, MD; Michael C. Sanguinetti, PhD Background Long QT syndrome
More informationA Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated by Mexiletine: The Role of Epinephrine Provocation Test
Case Report http://dx.doi.org/10.3349/ymj.2013.54.2.529 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 54(2):529-533, 2013 A Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated
More informationTitle The Mental Health of Adolescents Living with Potentially Fatal Arrhythmia: A Systematic Review of the Literature
PROSPERO Registration of Systematic Review Title The Mental Health of Adolescents Living with Potentially Fatal Arrhythmia: A Systematic Review of the Literature Registration - - - to be registered in
More informationLecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)
Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs) Single nucleotide polymorphisms or SNPs (pronounced "snips") are DNA sequence variations that occur
More informationJanuary 14-15, 2011 SCA Conference 2
Electrical Abnormalities: Long QT and Beyond Yaniv Bar-Cohen, M.D. Assistant Professor of Pediatrics Division of Cardiology / Electrophysiology Childrens Hospital Los Angeles Keck School of Medicine Genetic
More informationThe Long-QT Syndrome: A Silent Killer
The Long-QT Syndrome: A Silent Killer Claire Crowley CLINICAL POINTS The long-qt syndrome can be inherited or acquired. It affects the function of cardiac ion channels and is characterised by a prolonged
More informationPreviously Published Works UC San Francisco
Previously Published Works UC San Francisco A University of California author or department has made this article openly available. Thanks to the Academic Senate s Open Access Policy, a great many UC-authored
More informationLong QT syndrome: from channels to cardiac arrhythmias
Review series Long QT syndrome: from channels to cardiac arrhythmias Arthur J. Moss 1 and Robert S. Kass 2 1 Heart Research Follow-up Program, Department of Medicine, University of Rochester School of
More informationLQTS Gene LOVD Database
HUMAN MUTATION Database in BRIEF 31: E1801-E1810 (2010) Online DATABASE IN BRIEF HUMAN MUTATION LQTS Gene LOVD Database OFFICIAL JOURNAL www.hgvs.org Tao Zhang 1,2 *, Arthur Moss 3.*, Peikuan Cong 2,*,
More informationHeritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait
TWINS AND GENETICS TWINS Heritability: Twin Studies Twin studies are often used to assess genetic effects on variation in a trait Comparing MZ/DZ twins can give evidence for genetic and/or environmental
More informationLife Threatening EKG s In The Office. Joseph A Manfredi, MD, FACC, FHRS GHS Cardiovascular Symposium
Life Threatening EKG s In The Office Joseph A Manfredi, MD, FACC, FHRS GHS Cardiovascular Symposium January 24 th, 2015 Disclosures Speaker Honorariums: STJM, Boston Scientific Advisory role: Medtronic
More informationThe functional characterisation of
Review Article Hellenic J Cardiol 2012; 53: 439-446 Effects of Mutations and Genetic Overlap in Inherited Long-QT and Brugada Arrhythmia Syndromes Christina-Maria Kotta, Aris Anastasakis, Christodoulos
More informationBreast cancer and the role of low penetrance alleles: a focus on ATM gene
Modena 18-19 novembre 2010 Breast cancer and the role of low penetrance alleles: a focus on ATM gene Dr. Laura La Paglia Breast Cancer genetic Other BC susceptibility genes TP53 PTEN STK11 CHEK2 BRCA1
More informationBecker Muscular Dystrophy
Muscular Dystrophy A Case Study of Positional Cloning Described by Benjamin Duchenne (1868) X-linked recessive disease causing severe muscular degeneration. 100 % penetrance X d Y affected male Frequency
More informationFit, (falls) and funny turns. Richard J Davenport Consultant Neurologist Edinburgh
Fit, (falls) and funny turns Richard J Davenport Consultant Neurologist Edinburgh The plan Epilepsy nuggets 10 things I would like GPs to know This week s FS clinic What is epilepsy? Characterised by two
More informationGene mutation and molecular medicine Chapter 15
Gene mutation and molecular medicine Chapter 15 Lecture Objectives What Are Mutations? How Are DNA Molecules and Mutations Analyzed? How Do Defective Proteins Lead to Diseases? What DNA Changes Lead to
More informationHLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of
1 HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study Lotus Mallbris, MD, PhD, Katarina Wolk, MD, Fabio Sánchez
More informationLong-QT syndrome (LQTS) is a cardiovascular disorder
Spectrum of Mutations in Long-QT Syndrome Genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 Igor Splawski, PhD; Jiaxiang Shen, MS; Katherine W. Timothy, BS; Michael H. Lehmann, MD; Silvia Priori, MD, PhD; Jennifer
More informationRisk Factors for Alcoholism among Taiwanese Aborigines
Risk Factors for Alcoholism among Taiwanese Aborigines Introduction Like most mental disorders, Alcoholism is a complex disease involving naturenurture interplay (1). The influence from the bio-psycho-social
More informationApplication for a Marketing Authorisation: Requirements and Criteria for the Assessment of QT Prolonging Potential
Application for a Marketing Authorisation: Requirements and Criteria for the Assessment of QT Prolonging Potential Bundesinstitut für Arzneimittel Dr. med. Clemens Mittmann Bundesinstitut für Arzneimittel
More informationhttp://nurse practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx
http://nurse practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx Alcohol Abuse By Neva K.Gulsby, PA-C, and Bonnie A. Dadig, EdD, PA-C Posted on: April 18, 2013 Excessive
More informationPotential Causes of Sudden Cardiac Arrest in Children
Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are
More informationClinical Perspective. Molecular genetics of inherited long QT syndromes. The long QT syndrome. Introduction. Clinical aspects/diagnostic criteria
European Heart Journal (1998) 19, 1427 1433 Article No. hj980873 Clinical Perspective Molecular genetics of inherited long QT syndromes Introduction Unravelling the molecular cause of QT prolongation is
More informationEpilepsy12 National Audit Round 2 Final Unit Report for: University Hospital of North Tees and Hartlepool
United Kingdom collaberative clinical audit of health care for children and young people with suspected epileptic seizures Epilepsy12 National Audit Round 2 Final Unit Report for: University Hospital of
More informationGenetic Testing in the Long QT Syndrome
ORIGINAL CONTRIBUTION Genetic Testing in the Long QT Syndrome Development and Validation of an Efficient Approach to Genotyping in Clinical Practice Carlo Napolitano, MD, PhD Silvia G. Priori, MD, PhD
More informationSudden unexplained death in infancy and long QT syndrome. Jonathan Robert Skinner
Sudden unexplained death in infancy and long QT syndrome. Jonathan Robert Skinner Greenlane Paediatric and Congenital Cardiac Services, Starship Children s Hospital, Park Road, Grafton, Auckland New Zealand.
More informationGenomes and SNPs in Malaria and Sickle Cell Anemia
Genomes and SNPs in Malaria and Sickle Cell Anemia Introduction to Genome Browsing with Ensembl Ensembl The vast amount of information in biological databases today demands a way of organising and accessing
More informationGenetics for preventative cardiology. Objectives HEART DISEASE COMES IN MANY FORMS!
Genetics for preventative cardiology Robert Nussbaum, MD Chief of Genomic Medicine, UCSF Medical Center; Co-Director, Program in Cardiovascular Genetics, UCSF Heart and Vascular Center Julianne Wojciak,
More informationLong QT syndrome! Should we treat all asymptomatic patients?!
! Long QT syndrome! Should we treat all asymptomatic patients?! Venice Arrhythmia 2015! Arthur A.M. Wilde Heart Centre NO CONFLICT OF INTEREST TO DECLARE Long QT Syndrome(s) Autosomal dominant/autosomal
More informationAn Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip
An Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip Joints Introduction Maezawa et al., have reported that
More informationElectrocardiographic Issues in Williams Syndrome
Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital
More informationGENOMICS: REINVIGORATING THE FIELD OF PSYCHIATRIC RESEARCH
Office of Communications www.broadinstitute.org T 617-714-7151 communications@broadinstitute.org 7 Cambridge Center, Cambridge, MA 02142 GENOMICS: REINVIGORATING THE FIELD OF PSYCHIATRIC RESEARCH For decades,
More informationL ong QT syndrome causes sudden
LEADING ARTICLE 445 Cardiology... Is there a relation between SIDS and long QT syndrome? J R Skinner... A discussion of the evidence to date L ong QT syndrome causes sudden unexpected death through rapid
More informationMUTATION, DNA REPAIR AND CANCER
MUTATION, DNA REPAIR AND CANCER 1 Mutation A heritable change in the genetic material Essential to the continuity of life Source of variation for natural selection New mutations are more likely to be harmful
More informationLong QT Syndrome Genetic Testing for Inherited Arrhythmias. patient guide
Long QT Syndrome Genetic Testing for Inherited Arrhythmias patient guide What is Long QT Syndrome? Arrhythmias are problems with the electrical system in the heart that controls the heartbeat s regular
More informationGenetic Mutations Cause Many Birth Defects:
Genetic Mutations Cause Many Birth Defects: What We Learned from the FORGE Canada Project Jan M. Friedman, MD, PhD University it of British Columbia Vancouver, Canada I have no conflicts of interest related
More informationCystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program
Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Introduction: Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and
More informationWhat Does It Mean to have a Gene?
CHAPTER 25 What Does It Mean to have a Gene? by Walter Allan, M.D. More than a year after we had sent the blood samples on Kara, Guerin, Tom and Maryann to Dr. Mark Keating s lab in Salt Lake City we still
More informationOverview of Inherited Heart Rhythm Disorders for Patients
Introduction Overview of Inherited Heart Rhythm Disorders for Patients Inherited heart rhythm disorders affect a small portion of the population, presenting as palpitations, fainting, heart arrest and
More informationNon-epileptic seizures
Non-epileptic seizures a short guide for patients and families Information for patients Department of Neurology Royal Hallamshire Hospital What are non-epileptic seizures? In a seizure people lose control
More informationGenetic analysis of Brugada syndrome and congenital long- QT syndrome type 3 in the Chinese
JCDR Original Paper Genetic analysis of Brugada syndrome and congenital long- QT syndrome type 3 in the Chinese Peng Liang, Wenling Liu 1, Cuilan Li 1, Wuhua Tao 2, Lei Li 1, Dayi Hu 1 Heart Center, Beijing
More informationGuidelines for the diagnosis and management of Familial Long QT Syndrome
The Cardiac Society of Australia and New Zealand Guidelines for the diagnosis and management of Familial Long QT Syndrome These guidelines were revised by Dr Jonathan Skinner and a members of the Cardiovascular
More informationNeurological System Best Practice Documentation
Neurological System Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Dementia Delirium/Encephalopathy Parkinson s Epilepsy /Seizure Migraines
More informationInnovation Platform: Sudden Cardiac Death
Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration
More informationINTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia
INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Cardiac Ion Channelopathies File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_cardiac_ion_channelopathies 10/2008 4/2015
More informationCoronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
More informationThe Human Genome Project. From genome to health From human genome to other genomes and to gene function Structural Genomics initiative
The Human Genome Project From genome to health From human genome to other genomes and to gene function Structural Genomics initiative June 2000 What is the Human Genome Project? U.S. govt. project coordinated
More informationDIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria
DIABETES MELLITUS By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria What is Diabetes Diabetes Mellitus (commonly referred to as diabetes ) is a chronic medical
More informationGenetic Testing in Research & Healthcare
We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes
More informationAtrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
More informationNORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1
NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle
More informationPreconception Clinical Care for Women Medical Conditions
Preconception Clinical Care for Women All women of reproductive age are candidates for preconception care; however, preconception care must be tailored to meet the needs of the individual. Given that preconception
More informationGene Therapy and Genetic Counseling. Chapter 20
Gene Therapy and Genetic Counseling Chapter 20 What is Gene Therapy? Treating a disease by replacing, manipulating or supplementing a gene The act of changing an individual s DNA sequence to fix a non-functional
More informationELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits
VI: 2 ELEMENTS FOR A PUBLIC SUMMARY Bicalutamide (CASODEX 1 ) is a hormonal therapy anticancer agent, used for the treatment of prostate cancer. Hormones are chemical messengers that help to control the
More informationAccelerated Protection. Do I need Critical Illness insurance?
Accelerated Protection Do I need Critical Illness insurance? Are you prepared? It s a fact of life that we all get sick, and sometimes seriously. The cost of recovery from an illness like cancer or heart
More informationSickle cell anemia: Altered beta chain Single AA change (#6 Glu to Val) Consequence: Protein polymerizes Change in RBC shape ---> phenotypes
Protein Structure Polypeptide: Protein: Therefore: Example: Single chain of amino acids 1 or more polypeptide chains All polypeptides are proteins Some proteins contain >1 polypeptide Hemoglobin (O 2 binding
More informationCholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia
More informationMedical Policy Manual. Topic: Genetic Testing for Cardiac Ion Channelopathies Date of Origin: December 2012
Medical Policy Manual Topic: Genetic Testing for Cardiac Ion Channelopathies Date of Origin: December 2012 Section: Genetic Testing Last Reviewed Date: December 2015 Policy No: 07 Effective Date: January
More informationSouthern Grampians & Glenelg Shires COMMUNITY PROFILE
Southern Grampians & Glenelg Shires COMMUNITY PROFILE Contents: 1. Health Status 2. Health Behaviours 3. Public Health Issues 4. References This information was last updated on 14 February 2007 1. Health
More informationDeveloping VA GDx: An Informatics Platform to Capture and Integrate Genetic Diagnostic Testing Data into the VA Electronic Medical Record
Developing VA GDx: An Informatics Platform to Capture and Integrate Genetic Diagnostic Testing Data into the VA Electronic Medical Record Scott L. DuVall Jun 27, 2014 1 Julie Lynch Vickie Venne Dawn Provenzale
More informationEHRs and large scale comparative effectiveness research
EHRs and large scale comparative effectiveness research September 16, 2014 Dana C. Crawford, PhD Associate Professor Epidemiology and Biostatistics Institute for Computational Biology Single Nucleotide
More informationSummary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole)
EMA/303592/2015 Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole) This is a summary of the risk management plan (RMP) for Aripiprazole Pharmathen, which details the measures
More informationHow to read the ECG in athletes: distinguishing normal form abnormal
How to read the ECG in athletes: distinguishing normal form abnormal Antonio Pelliccia, MD Institute of Sport Medicine and Science www.antoniopelliccia.it Cardiac adaptations to Rowing Vagotonia Sinus
More informationKey Facts about Influenza (Flu) & Flu Vaccine
Key Facts about Influenza (Flu) & Flu Vaccine mouths or noses of people who are nearby. Less often, a person might also get flu by touching a surface or object that has flu virus on it and then touching
More informationUsefulness of Epinephrine Test in the Congenital Long QT Syndrome
Usefulness of Epinephrine Test in the Congenital Long QT Syndrome Wataru Shimizu M.D., Ph.D. CASE PRESENTATION A 14-year old Japanese boy was successfully resuscitated from cardiac arrest (near drowning)
More informationLQTS: Long QT Syndrome. Inherited Heart Disease Clinic
2011 LQTS: Long QT Syndrome Inherited Heart Disease Clinic What is LQTS? LQTS is a rare heart rhythm disorder. It causes a disruption of the electrical signal that stimulates your heart to beat. It occurs
More informationThe Developing Person Through the Life Span 8e by Kathleen Stassen Berger
The Developing Person Through the Life Span 8e by Kathleen Stassen Berger Chapter 3 Heredity and Environment PowerPoint Slides developed by Martin Wolfger and Michael James Ivy Tech Community College-Bloomington
More informationVoluntary Benefits Employee Enrollment and Change Form
Voluntary Benefits Employee Enrollment and Change Form LifeMap Assurance Company TM For residents of Oregon and Washington, the definition of a Spouse includes your legal husband or wife or your State
More informationPharmacogenetics of Topiramate Treatment for Heavy Drinking
Pharmacogenetics of Topiramate Treatment for Heavy Drinking Henry R. Kranzler, M.D. Perelman School of Medicine of the University of Pennsylvania and VISN 4 MIRECC, Philadelphia VAMC kranzler@mail.med.upenn.edu
More informationChest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.
Chest Pain in Young Athletes Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.org 858-966-5855 None Disclosures Chest Pain: the good news and the bad news:
More informationOsama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015
STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:
More informationPeople First Language. Style Guide. A reference for media professionals and the public
People First Language Style Guide A reference for media professionals and the public What is People First Language? People First Language (also referred to as Person First ) is an accurate way of referring
More informationCHILD DEATH & SERIOUS INJURY REVIEW COMMITTEE ANNUAL REPORT 2012 13
CHILD DEATH & SERIOUS INJURY REVIEW COMMITTEE ANNUAL REPORT 2012 13 i LETTER OF TRANSMISSION Hon Jennifer Rankine MP Minister for Education and Child Development Dear Minister I submit to you for presentation
More informationPREMIER PAIN CARE PA Carlos J Garcia MD 2435 W. Oak Street # 103 Denton, TX 76201 Phone 940-323-9404 Fax 940-323-9422 PATIENT REGISTRATION
PREMIER PAIN CARE PA Carlos J Garcia MD 2435 W. Oak Street # 103 Denton, TX 76201 Phone 940-323-9404 Fax 940-323-9422 PATIENT REGISTRATION Last Name First Name MI Mailing Address City Zip code Home Phone
More informationALCOHOLISM, ALCOHOL DEPENDENCE AND THE EFFECTS ON YOUR HEALTH.
ALCOHOLISM, ALCOHOL DEPENDENCE AND THE EFFECTS ON YOUR HEALTH. Alcoholism also known as alcohol dependence is a disabling ADDICTIVE DISORDER. It is characterized by compulsive and uncontrolled consumption
More informationNext Generation Sequencing. mapping mutations in congenital heart disease
Next Generation Sequencing mapping mutations in congenital heart disease AV Postma PhD Academic Medical Center Amsterdam, the Netherlands Overview talk Congenital heart disease and genetics Next generation
More informationMental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
More informationCardiovascular Disease and Maternal Mortality what do we know and what are the key questions?
Cardiovascular Disease and Maternal Mortality what do we know and what are the key questions? AFSHAN HAMEED, MD, FACOG, FACC Associate Clinical Professor Maternal Fetal Medicine and Cardiology University
More information75-09.1-08-02. Program criteria. A social detoxi cation program must provide:
CHAPTER 75-09.1-08 SOCIAL DETOXIFICATION ASAM LEVEL III.2-D Section 75-09.1-08-01 De nitions 75-09.1-08-02 Program Criteria 75-09.1-08-03 Provider Criteria 75-09.1-08-04 Admission and Continued Stay Criteria
More informationDental Admission Form
Dental Admission Form PERSONAL HISTORY All of the information which you provide on this form will be held in the strictest confidence. Although some questions may seem unimportant at the time, they may
More informationINTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia
INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs
More informationEpinephrine-Induced QT Interval Prolongation: A Gene-Specific Paradoxical Response in Congenital Long QT Syndrome
Mayo Clin Proc, May 2002, Vol 77 Infusion QT Stress Testing in LQTS 413 Original rticle -Induced QT Interval Prolongation: Gene-Specific Paradoxical Response in Congenital Long QT Syndrome MICHEL J. CKERMN,
More information% of time working at heights % What is the average height you work at?
Relevant for Income Protection cases only: 18 Do any of the following form an essential part of your work? a manual work YES NO % of time at Manual work % b Driving YES NO % of time Driving % Average weekly
More informationBioBoot Camp Genetics
BioBoot Camp Genetics BIO.B.1.2.1 Describe how the process of DNA replication results in the transmission and/or conservation of genetic information DNA Replication is the process of DNA being copied before
More informationHeadaches and Kids. Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital
Headaches and Kids Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital Overview Headache classifications and diagnosis Address common headache
More informationVoluntary Benefits Employee Enrollment and Change Form
LifeMap Assurance Company TM P.O. Box 1271, MS E-3A Portland, OR 97207-1271 (503) 721-7161 (800) 794-5390 Voluntary Benefits Employee Enrollment and Change Form For residents of Oregon and Washington,
More informationChapter 4: Eligibility Categories
23 Chapter 4: Eligibility Categories In this chapter you will: learn the different special education categories 24 IDEA lists different disability categories under which children may be eligible for services.
More informationNovartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf
More informationtrust clinical guideline
CG23 VERSION 1.0 1/7 Guideline ID CG23 Version 1.0 Title Approved by Transient Loss of Consciousness Clinical Effectiveness Group Date Issued 01/01/2013 Review Date 31/12/2016 Directorate Authorised Staff
More informationType 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment Bruce Latham, M.D. Endocrine Specialists Greenville Health System Objectives for this presentation - Understand the thrifty genotype
More information6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.
High Prevalence and Incidence Prevalence 85% of Americans will experience low back pain at some time in their life. Incidence 5% annual Timothy C. Shen, M.D. Physical Medicine and Rehabilitation Sub-specialty
More informationNational Medical Policy
National Medical Policy Subject: Policy Number: Genetic Testing for Long QT Syndrome NMP490 Effective Date*: February 2005 Updated: August 2015 This National Medical Policy is subject to the terms in the
More informationDepression and Mental Health:
Depression and Mental Health: A Psychiatrist s Perspective Peter M. Lake, MD Medical Director Rogers Memorial Hospital Oconomowoc Depression The Intersection of Hope, Medicine and Research Marquette University
More information